JG
Jon D. Gabbard

Highly Cited

47
Works
1,027
Citations
18
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5043323250
  • i10-Index 24
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

Jon D. Gabbard

Also known as: J. Gabbard, Jon D Gabbard, Jon D. Gabbard, Jon Gabbard

47

Total Works

1,027

Citations

18

H-Index

24

i10-Index

Citation & Works Trend by Year
21 years active
Top Research Topics
Influenza Virus Research Studies (23) Virology and Viral Diseases (17) SARS-CoV-2 and COVID-19 Research (11) Respiratory viral infections research (10) Immune responses and vaccinations (9)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Neutrophil control of immune cell recruitment and acute lung injury in SARS-CoV-2-infected mice American Journal of Physiology-Lung Cellular and Molecular Physiology 0
2026 Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2 Biomedicine & Pharmacotherapy 2
2025 NMDA receptor antagonists mitigate COVID-19-induced neuroinflammation and improve survival in a mouse model Scientific Reports 3
2025 Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort Vaccines 4
2025 Impact of chronic ethanol consumption and SARS ‐ COV ‐2 on the liver and intestine: A pilot dose–response study in mice Alcoholism Clinical and Experimental Research 0
2024 Regulation of Paneth cell-specific genes in COVID-19 patients and SARS-CoV-2-infected mice by quantification of mRNA from exfoliated cells in stool samples Scientific Reports 3
2024 Mo1536 ENDOGENOUS ENRICHMENT IN OMEGA 3 FATTY ACIDS ATTENUATED LIVER INJURY CAUSED BY CHRONIC ETHANOL CONSUMPTION AND SARS-COV-2 INFECTION IN MICE Gastroenterology 0
2023 Efficacy of a brain-penetrant antiviral in lethal Venezuelan and eastern equine encephalitis mouse models Science Translational Medicine 10
2022 Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains Microbiology Spectrum 8
2022 Validated Preclinical Murine Model for Therapeutic Testing against Multidrug Resistant Pseudomonas aeruginosa bioRxiv (Cold Spring Harbor Laboratory) 1
2022 Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses Science Advances 135
2021 CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology Vaccines 5
2021 At the Intersection Between SARS-CoV-2, Macrophages and the Adaptive Immune Response: A Key Role for Antibody-Dependent Pathogenesis But Not Enhancement of Infection in COVID-19 bioRxiv (Cold Spring Harbor Laboratory) 3
2020 507. Activation of Macrophages Enhances Susceptibility to SARS-CoV-2 Antibody-Dependent Enhancement and Promotes Damage to Downstream Epithelial Cells Open Forum Infectious Diseases 0
2019 Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses Antiviral Research 22

Data source: OpenAlex API